SlideShare a Scribd company logo
P r e s e n t e d b y : S h i v a m
M. Pharm I year Pharmacology
Under the Guideline of: Dr. Phoolchandra
D e p a r t m e n t o f P h a r m a c o l o g y
SCREENING OF
IMMUNOMODULATORS
School of Pharmaceutical Science
I F T M U n i v e r s i t y
M o r a d a b a d
IMMUNOMODULATORS
• Immunomodulators are the agents that
modulates the immune system by suppress
or depress the immune system. So, these are
also divide into two parts
• 1- Immunosuppressant
• 2- Immunostimulants
IMMUNESUPRESSENTS
• Immunosuppressive drugs are used to
dampen the immune response in the organ
transplantation and autoimmune disease.
a) Specific T-cell inhibitors: Cyclosporine, Tacrolimus
b) Cyclotoxic drugs: Azathioprine, Cyclophospamide,
Methottraxate, Chlorambusil, Mycophenolate
c) Glucocorticoids: Prednisolone
d) Antibodies: Muromonab CD3, Antithymocyte
globulin(ATG), Rho(D), Immunoglobulin
IMMUNOSTIMULANTS
• These drugs are used to stimulate the immune
response in case of immunodeficiency.
• a) Levamisole (ergamisole)
• b)Thalidomide (Thalomid)
• c) Bacillus Calmette- Guerin (BCG)
• d) Interferons- gamma 1b & 1a
• e) Interleukin-2
Screening Methods
• Acute systemic anaphylaxix in rats
• Anti-anaphylactic activity (schuitz-dale reaction)
• Passive cutaneus anaphylaxis
• Arthus type immediate hypersensitivity
• Delayed type hyper sensitivity
• Reversed passive arthus reaction
• Adjuvant arthritis in rats
1. Acute systemic anaphylaxis in rats
• Strain 10-20 female Sprague-Dawley rat (120g)
• Firstly immunized by i.m. injection of 10 mg/kg
highly purified ovalbumin.
• Simultaneously 1 ml of Bordetella pertusis
suspension injected intraperitoneally.
• After 11 days animals injected with i.v. injection
of 25 mg/kg highly purified obalbumin
• 18hr prior to challenge, test dexamethasone 1-
10mg/kg s.c. control vehicle.
• Evalution:
after treatment compared treated and
control group for their shock symptoms and
mortality counted.
Statistical calculation is performed using
the chi-square test.
Modification
• By Devis and Evans(1973)- this experiment have also
been performed in guniea pigs and in mice. Anaphylactic
bronchospasm can be measured in isolated guniea pig
lungs.
• By Ufkes and Ottenhoff (1984)- study on brown norway
rats.
Given a suspension of trinitrophenyl heptenized ovalbulin
together with aipo4.
Bronchial and cardiiovascular function were studied after
treatment with antiallergic agents and antigen challenge.
2. Anti anaphylactic Activity
• Animal guinea pig of both sex
• Body weight 300-350g
• Sensitized with alum precipitated egg
albumin
• Give injection of 0.125 ml of egg albumin
in each foot pad and 0.5 ml
subcutaneously.
• After four weeks animal are killed and the
ileum is dissected out.
• About 2-3 cm long are mounted in an organ
bath containing Tyrode solution at
37cetigrate.
• Contractility of the ileum strips is tested by
adding standard in one organ bath and test
compound in another organ bath.
Biochemical estimation
• Carbon clearance test- for phagocytic
response
phagocytic Index = K(sample)/K(control)
• Hemagglutinating antibody titer.
Evalution-
• The concentration are recorded by a
polygraph
Modification-
• This method modified by testing histamine
release lung after challenging with egg
albumin.
• Koppel et al.(1981) developed a method to
induce concentration of mouse trachea by
antigen.
• Omote et al. (1994) modified method by using
sensitized guinea pigs.
3. Passive coetaneous anaphylaxis
• Animal- male rats
• Body weight- 100 g
principle:
Formation of antigen antibody complex induce
the release of mediator from mast cells. This
results increase in permeability of the vessel
walls and leakage of plasma.
Procedure
• Antiserum are injected intradermally in to shaved dorsal
skin of rats.
• After 24hr each animal is challenged with the
intravenous administration of 0.1ml of 2.5% Evans blue
dye containing 25mg/ml of egg albumin.
• Test compound is also administer along with the antigen.
• After 30 min animals are scarified.
• Amount of Evans blue dye that leaked at the site of
reaction is extracted and determined calorimetrically at
620 milimicron wavelength.
Evaluation
• Amount of Evans blue that extracted from
passive coetaneous anaphylactic reaction of
control group is compared group.
Modification
• Gose and Blair (1969)- used Bordetella pert sis
as antigen in passive coetaneous anaphylaxis
experi
4. Arthus type immediate hypersensitivity
• Animal-rats of both sex
• Strain-Wistar or Spargue- Dawley
• Body weight 220-280g
Principle-
• Antigen antibody induced reaction to an
inflammatory factors that characterized by
edeme, hemorrhage and vasculitis.
Procedure
• Seven days prior to experiment rats are sensitized
by im administration of 0.5 ml of the ovalabulin
suspension.
• 1st group (treated group) 1hr prior test compound
are administered and challenged with 0.5ml of
ovalabulin in left hind paw
• 2nd group(positive group)-sensitized animal
treated with solvent alone.
• 3rd group (negative group) non sensitized animals
treated with solvent.
Evaluation
• The change in footpad thickness is expressed
as percent from the vehicle control group.
Thickness can be measured by calipers.
Modification
• Omote et al.(1994)-sheep red blood cell
suspension used for immunization.
5. Delayed type hypersensitivity
Principle
• Delayed type hypersensitivity is a reaction of
cell mediated immunity and becomes visible
after 16-18hr.
Procedure
• 7 days prior, rats are sensitized by im
administration of 0.5 ml ovalbulin.
• After seven days again 0.1 of 0.04% of
ovalbulin injected in the left hind paw.
• Footpad thickness is measured immediately
and 24hr after of administration.
Modification
• Mizukoshi et al.(1994)- they use sheep red
blood cells for immunization.
Screening methods of immunomodulators by shivam diwaker

More Related Content

What's hot

Screening methods of immunomodulators
Screening methods of immunomodulatorsScreening methods of immunomodulators
Screening methods of immunomodulators
Aanchal46
 
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEEDScreening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Abdul Hameed
 
Multiple sclerosis screening methods
Multiple sclerosis screening methodsMultiple sclerosis screening methods
Multiple sclerosis screening methods
mohamed abusalih
 
Screening of anti anxiety drugs
Screening of anti anxiety drugsScreening of anti anxiety drugs
Screening of anti anxiety drugsBindu Pulugurtha
 
Screening methods of immunomodulatory drugs
Screening methods of  immunomodulatory drugsScreening methods of  immunomodulatory drugs
Screening methods of immunomodulatory drugsPrafulla Tiwari
 
Screening models of anti psychotic drugs-converted
Screening models of anti psychotic drugs-convertedScreening models of anti psychotic drugs-converted
Screening models of anti psychotic drugs-converted
B V V S Hanagal Shri Kumareshwar College of Pharmacy, Bagalkote
 
Alternative animal experimentation technique
Alternative animal experimentation techniqueAlternative animal experimentation technique
Alternative animal experimentation technique
KARNATAKA COLLEGE OF PHARMACY
 
Preclinical screening of new substance for pharmacological activity
Preclinical screening of new substance for pharmacological activityPreclinical screening of new substance for pharmacological activity
Preclinical screening of new substance for pharmacological activity
ShrutiGautam18
 
Assignment on Preclinical Screening of Immunomodulators
Assignment on Preclinical Screening of ImmunomodulatorsAssignment on Preclinical Screening of Immunomodulators
Assignment on Preclinical Screening of Immunomodulators
Deepak Kumar
 
Immunoassay of digoxin
Immunoassay of digoxinImmunoassay of digoxin
Immunoassay of digoxin
Rashmi116
 
Screening of anti emetics drug
Screening of anti emetics drugScreening of anti emetics drug
Screening of anti emetics drug
Rajeshwar Yadav
 
Preclinical Screening of Antipsychotic Agents
Preclinical Screening of Antipsychotic Agents Preclinical Screening of Antipsychotic Agents
Preclinical Screening of Antipsychotic Agents
Anurag Chourasia
 
Screening models for immunomodulator
Screening models for immunomodulatorScreening models for immunomodulator
Screening models for immunomodulator
Mr. MOHD FAHAD
 
Theoretical basis and optimization of immunoassay
Theoretical basis and optimization of immunoassayTheoretical basis and optimization of immunoassay
Theoretical basis and optimization of immunoassay
AkankshDas
 
Screening Methods of Parkinson's Disease
Screening Methods of Parkinson's DiseaseScreening Methods of Parkinson's Disease
Screening Methods of Parkinson's Disease
Anupam dubey
 
screening methods for Antiepileptic activity
screening methods for Antiepileptic activityscreening methods for Antiepileptic activity
screening methods for Antiepileptic activitySravanthi Shetty
 
Screening of antiparkinsonian agents
Screening of antiparkinsonian agentsScreening of antiparkinsonian agents
Screening of antiparkinsonian agents
Dr. Mallappa Shalavadi
 
Anti epileptic screening model
Anti epileptic screening modelAnti epileptic screening model
Anti epileptic screening model
KhushbooThakur15
 
Screening of depressents by Kashikant Yadav
Screening of depressents  by Kashikant YadavScreening of depressents  by Kashikant Yadav
Screening of depressents by Kashikant Yadav
Kashikant Yadav
 
Screening Models Of Anti Cancer Drugs
Screening Models Of Anti Cancer DrugsScreening Models Of Anti Cancer Drugs

What's hot (20)

Screening methods of immunomodulators
Screening methods of immunomodulatorsScreening methods of immunomodulators
Screening methods of immunomodulators
 
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEEDScreening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
 
Multiple sclerosis screening methods
Multiple sclerosis screening methodsMultiple sclerosis screening methods
Multiple sclerosis screening methods
 
Screening of anti anxiety drugs
Screening of anti anxiety drugsScreening of anti anxiety drugs
Screening of anti anxiety drugs
 
Screening methods of immunomodulatory drugs
Screening methods of  immunomodulatory drugsScreening methods of  immunomodulatory drugs
Screening methods of immunomodulatory drugs
 
Screening models of anti psychotic drugs-converted
Screening models of anti psychotic drugs-convertedScreening models of anti psychotic drugs-converted
Screening models of anti psychotic drugs-converted
 
Alternative animal experimentation technique
Alternative animal experimentation techniqueAlternative animal experimentation technique
Alternative animal experimentation technique
 
Preclinical screening of new substance for pharmacological activity
Preclinical screening of new substance for pharmacological activityPreclinical screening of new substance for pharmacological activity
Preclinical screening of new substance for pharmacological activity
 
Assignment on Preclinical Screening of Immunomodulators
Assignment on Preclinical Screening of ImmunomodulatorsAssignment on Preclinical Screening of Immunomodulators
Assignment on Preclinical Screening of Immunomodulators
 
Immunoassay of digoxin
Immunoassay of digoxinImmunoassay of digoxin
Immunoassay of digoxin
 
Screening of anti emetics drug
Screening of anti emetics drugScreening of anti emetics drug
Screening of anti emetics drug
 
Preclinical Screening of Antipsychotic Agents
Preclinical Screening of Antipsychotic Agents Preclinical Screening of Antipsychotic Agents
Preclinical Screening of Antipsychotic Agents
 
Screening models for immunomodulator
Screening models for immunomodulatorScreening models for immunomodulator
Screening models for immunomodulator
 
Theoretical basis and optimization of immunoassay
Theoretical basis and optimization of immunoassayTheoretical basis and optimization of immunoassay
Theoretical basis and optimization of immunoassay
 
Screening Methods of Parkinson's Disease
Screening Methods of Parkinson's DiseaseScreening Methods of Parkinson's Disease
Screening Methods of Parkinson's Disease
 
screening methods for Antiepileptic activity
screening methods for Antiepileptic activityscreening methods for Antiepileptic activity
screening methods for Antiepileptic activity
 
Screening of antiparkinsonian agents
Screening of antiparkinsonian agentsScreening of antiparkinsonian agents
Screening of antiparkinsonian agents
 
Anti epileptic screening model
Anti epileptic screening modelAnti epileptic screening model
Anti epileptic screening model
 
Screening of depressents by Kashikant Yadav
Screening of depressents  by Kashikant YadavScreening of depressents  by Kashikant Yadav
Screening of depressents by Kashikant Yadav
 
Screening Models Of Anti Cancer Drugs
Screening Models Of Anti Cancer DrugsScreening Models Of Anti Cancer Drugs
Screening Models Of Anti Cancer Drugs
 

Similar to Screening methods of immunomodulators by shivam diwaker

Screening models for immunomodulatory agents
Screening models for immunomodulatory agentsScreening models for immunomodulatory agents
Screening models for immunomodulatory agents
Chandragiri Siva Sai
 
Immunodulators Screening methods
Immunodulators Screening methodsImmunodulators Screening methods
Immunodulators Screening methods
ANANYAPANDEY71
 
SCREENING OF immuno.pptx
SCREENING OF immuno.pptxSCREENING OF immuno.pptx
SCREENING OF immuno.pptx
SourinDe2
 
Screening models For immunosuppressants ..pptx
Screening models For immunosuppressants ..pptxScreening models For immunosuppressants ..pptx
Screening models For immunosuppressants ..pptx
RahulTipare
 
Screening of immunomodulatory drugs
Screening of immunomodulatory drugsScreening of immunomodulatory drugs
Screening of immunomodulatory drugs
Akshay Joshi
 
Immunoassay of insulin (neha)
Immunoassay of insulin (neha)Immunoassay of insulin (neha)
Immunoassay of insulin (neha)
ANANYAPANDEY71
 
immunoassayofinsulinneha-220207120331.pptx
immunoassayofinsulinneha-220207120331.pptximmunoassayofinsulinneha-220207120331.pptx
immunoassayofinsulinneha-220207120331.pptx
AbhishekMahajan510050
 
Antiallergic activity by mast cell stabilization assay
Antiallergic activity by mast cell stabilization assayAntiallergic activity by mast cell stabilization assay
Antiallergic activity by mast cell stabilization assay
HimikaRathi
 
Screening methods for Analgesics
Screening methods for AnalgesicsScreening methods for Analgesics
Screening methods for Analgesics
FoziyaKhan
 
Screening of analgesics
Screening of analgesics Screening of analgesics
Screening of analgesics
Asma Ashraf
 
Analgesic Screening Models
Analgesic Screening ModelsAnalgesic Screening Models
Analgesic Screening Models
MadhurimaSahay
 
Topic – Preclinical study of Immunomodulator
   Topic – Preclinical study of Immunomodulator    Topic – Preclinical study of Immunomodulator
Topic – Preclinical study of Immunomodulator
ShobhiniChandel
 
ANTIALLERGICS’.pptx
ANTIALLERGICS’.pptxANTIALLERGICS’.pptx
ANTIALLERGICS’.pptx
Ravilla Jyothsna Naidu
 
Invivo screening methods for anti inflammatory agents
Invivo screening methods for anti inflammatory  agentsInvivo screening methods for anti inflammatory  agents
Invivo screening methods for anti inflammatory agents
Sravani Ganti
 
Screening models(IN-VIVO) for analgesics and anti inflammatory agents
Screening models(IN-VIVO) for analgesics and anti inflammatory agentsScreening models(IN-VIVO) for analgesics and anti inflammatory agents
Screening models(IN-VIVO) for analgesics and anti inflammatory agents
MADHAV JAJNURE
 
Enzyme therapy
Enzyme therapyEnzyme therapy
Enzyme therapy
DrReuben Syiem
 
Screening of drugs used in arthritis
Screening of drugs used in arthritisScreening of drugs used in arthritis
Screening of drugs used in arthritis
Asma Ashraf
 
Pharmacological screening2 & tox. studies
Pharmacological screening2 & tox. studiesPharmacological screening2 & tox. studies
Pharmacological screening2 & tox. studies
Noor Alam
 
Screening methods of anxiolytics
Screening methods of anxiolyticsScreening methods of anxiolytics
Screening methods of anxiolytics
Jitendra Agrawal
 
Preclinical Models for Analgesic Drugs.pptx
Preclinical Models for Analgesic Drugs.pptxPreclinical Models for Analgesic Drugs.pptx
Preclinical Models for Analgesic Drugs.pptx
Renuka N Sunagad
 

Similar to Screening methods of immunomodulators by shivam diwaker (20)

Screening models for immunomodulatory agents
Screening models for immunomodulatory agentsScreening models for immunomodulatory agents
Screening models for immunomodulatory agents
 
Immunodulators Screening methods
Immunodulators Screening methodsImmunodulators Screening methods
Immunodulators Screening methods
 
SCREENING OF immuno.pptx
SCREENING OF immuno.pptxSCREENING OF immuno.pptx
SCREENING OF immuno.pptx
 
Screening models For immunosuppressants ..pptx
Screening models For immunosuppressants ..pptxScreening models For immunosuppressants ..pptx
Screening models For immunosuppressants ..pptx
 
Screening of immunomodulatory drugs
Screening of immunomodulatory drugsScreening of immunomodulatory drugs
Screening of immunomodulatory drugs
 
Immunoassay of insulin (neha)
Immunoassay of insulin (neha)Immunoassay of insulin (neha)
Immunoassay of insulin (neha)
 
immunoassayofinsulinneha-220207120331.pptx
immunoassayofinsulinneha-220207120331.pptximmunoassayofinsulinneha-220207120331.pptx
immunoassayofinsulinneha-220207120331.pptx
 
Antiallergic activity by mast cell stabilization assay
Antiallergic activity by mast cell stabilization assayAntiallergic activity by mast cell stabilization assay
Antiallergic activity by mast cell stabilization assay
 
Screening methods for Analgesics
Screening methods for AnalgesicsScreening methods for Analgesics
Screening methods for Analgesics
 
Screening of analgesics
Screening of analgesics Screening of analgesics
Screening of analgesics
 
Analgesic Screening Models
Analgesic Screening ModelsAnalgesic Screening Models
Analgesic Screening Models
 
Topic – Preclinical study of Immunomodulator
   Topic – Preclinical study of Immunomodulator    Topic – Preclinical study of Immunomodulator
Topic – Preclinical study of Immunomodulator
 
ANTIALLERGICS’.pptx
ANTIALLERGICS’.pptxANTIALLERGICS’.pptx
ANTIALLERGICS’.pptx
 
Invivo screening methods for anti inflammatory agents
Invivo screening methods for anti inflammatory  agentsInvivo screening methods for anti inflammatory  agents
Invivo screening methods for anti inflammatory agents
 
Screening models(IN-VIVO) for analgesics and anti inflammatory agents
Screening models(IN-VIVO) for analgesics and anti inflammatory agentsScreening models(IN-VIVO) for analgesics and anti inflammatory agents
Screening models(IN-VIVO) for analgesics and anti inflammatory agents
 
Enzyme therapy
Enzyme therapyEnzyme therapy
Enzyme therapy
 
Screening of drugs used in arthritis
Screening of drugs used in arthritisScreening of drugs used in arthritis
Screening of drugs used in arthritis
 
Pharmacological screening2 & tox. studies
Pharmacological screening2 & tox. studiesPharmacological screening2 & tox. studies
Pharmacological screening2 & tox. studies
 
Screening methods of anxiolytics
Screening methods of anxiolyticsScreening methods of anxiolytics
Screening methods of anxiolytics
 
Preclinical Models for Analgesic Drugs.pptx
Preclinical Models for Analgesic Drugs.pptxPreclinical Models for Analgesic Drugs.pptx
Preclinical Models for Analgesic Drugs.pptx
 

More from Shivam Diwaker

Anatomy and Physiology of Heart.pdf
Anatomy and Physiology of Heart.pdfAnatomy and Physiology of Heart.pdf
Anatomy and Physiology of Heart.pdf
Shivam Diwaker
 
Scope of Anatomy and physiology.pptx
Scope of Anatomy and physiology.pptxScope of Anatomy and physiology.pptx
Scope of Anatomy and physiology.pptx
Shivam Diwaker
 
Oral contraceptives by shivam
Oral contraceptives by shivamOral contraceptives by shivam
Oral contraceptives by shivam
Shivam Diwaker
 
Cerebral palsy by shivam
Cerebral palsy by shivamCerebral palsy by shivam
Cerebral palsy by shivam
Shivam Diwaker
 
Pharmacology of free radicals
Pharmacology of free radicalsPharmacology of free radicals
Pharmacology of free radicals
Shivam Diwaker
 
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Shivam Diwaker
 

More from Shivam Diwaker (6)

Anatomy and Physiology of Heart.pdf
Anatomy and Physiology of Heart.pdfAnatomy and Physiology of Heart.pdf
Anatomy and Physiology of Heart.pdf
 
Scope of Anatomy and physiology.pptx
Scope of Anatomy and physiology.pptxScope of Anatomy and physiology.pptx
Scope of Anatomy and physiology.pptx
 
Oral contraceptives by shivam
Oral contraceptives by shivamOral contraceptives by shivam
Oral contraceptives by shivam
 
Cerebral palsy by shivam
Cerebral palsy by shivamCerebral palsy by shivam
Cerebral palsy by shivam
 
Pharmacology of free radicals
Pharmacology of free radicalsPharmacology of free radicals
Pharmacology of free radicals
 
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
 

Recently uploaded

Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Atul Kumar Singh
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 

Recently uploaded (20)

Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 

Screening methods of immunomodulators by shivam diwaker

  • 1. P r e s e n t e d b y : S h i v a m M. Pharm I year Pharmacology Under the Guideline of: Dr. Phoolchandra D e p a r t m e n t o f P h a r m a c o l o g y SCREENING OF IMMUNOMODULATORS School of Pharmaceutical Science I F T M U n i v e r s i t y M o r a d a b a d
  • 2. IMMUNOMODULATORS • Immunomodulators are the agents that modulates the immune system by suppress or depress the immune system. So, these are also divide into two parts • 1- Immunosuppressant • 2- Immunostimulants
  • 3. IMMUNESUPRESSENTS • Immunosuppressive drugs are used to dampen the immune response in the organ transplantation and autoimmune disease. a) Specific T-cell inhibitors: Cyclosporine, Tacrolimus b) Cyclotoxic drugs: Azathioprine, Cyclophospamide, Methottraxate, Chlorambusil, Mycophenolate c) Glucocorticoids: Prednisolone d) Antibodies: Muromonab CD3, Antithymocyte globulin(ATG), Rho(D), Immunoglobulin
  • 4. IMMUNOSTIMULANTS • These drugs are used to stimulate the immune response in case of immunodeficiency. • a) Levamisole (ergamisole) • b)Thalidomide (Thalomid) • c) Bacillus Calmette- Guerin (BCG) • d) Interferons- gamma 1b & 1a • e) Interleukin-2
  • 5. Screening Methods • Acute systemic anaphylaxix in rats • Anti-anaphylactic activity (schuitz-dale reaction) • Passive cutaneus anaphylaxis • Arthus type immediate hypersensitivity • Delayed type hyper sensitivity • Reversed passive arthus reaction • Adjuvant arthritis in rats
  • 6. 1. Acute systemic anaphylaxis in rats • Strain 10-20 female Sprague-Dawley rat (120g) • Firstly immunized by i.m. injection of 10 mg/kg highly purified ovalbumin. • Simultaneously 1 ml of Bordetella pertusis suspension injected intraperitoneally. • After 11 days animals injected with i.v. injection of 25 mg/kg highly purified obalbumin • 18hr prior to challenge, test dexamethasone 1- 10mg/kg s.c. control vehicle.
  • 7. • Evalution: after treatment compared treated and control group for their shock symptoms and mortality counted. Statistical calculation is performed using the chi-square test.
  • 8. Modification • By Devis and Evans(1973)- this experiment have also been performed in guniea pigs and in mice. Anaphylactic bronchospasm can be measured in isolated guniea pig lungs. • By Ufkes and Ottenhoff (1984)- study on brown norway rats. Given a suspension of trinitrophenyl heptenized ovalbulin together with aipo4. Bronchial and cardiiovascular function were studied after treatment with antiallergic agents and antigen challenge.
  • 9. 2. Anti anaphylactic Activity • Animal guinea pig of both sex • Body weight 300-350g • Sensitized with alum precipitated egg albumin • Give injection of 0.125 ml of egg albumin in each foot pad and 0.5 ml subcutaneously.
  • 10. • After four weeks animal are killed and the ileum is dissected out. • About 2-3 cm long are mounted in an organ bath containing Tyrode solution at 37cetigrate. • Contractility of the ileum strips is tested by adding standard in one organ bath and test compound in another organ bath.
  • 11. Biochemical estimation • Carbon clearance test- for phagocytic response phagocytic Index = K(sample)/K(control) • Hemagglutinating antibody titer.
  • 12. Evalution- • The concentration are recorded by a polygraph Modification- • This method modified by testing histamine release lung after challenging with egg albumin. • Koppel et al.(1981) developed a method to induce concentration of mouse trachea by antigen. • Omote et al. (1994) modified method by using sensitized guinea pigs.
  • 13. 3. Passive coetaneous anaphylaxis • Animal- male rats • Body weight- 100 g principle: Formation of antigen antibody complex induce the release of mediator from mast cells. This results increase in permeability of the vessel walls and leakage of plasma.
  • 14. Procedure • Antiserum are injected intradermally in to shaved dorsal skin of rats. • After 24hr each animal is challenged with the intravenous administration of 0.1ml of 2.5% Evans blue dye containing 25mg/ml of egg albumin. • Test compound is also administer along with the antigen. • After 30 min animals are scarified. • Amount of Evans blue dye that leaked at the site of reaction is extracted and determined calorimetrically at 620 milimicron wavelength.
  • 15. Evaluation • Amount of Evans blue that extracted from passive coetaneous anaphylactic reaction of control group is compared group. Modification • Gose and Blair (1969)- used Bordetella pert sis as antigen in passive coetaneous anaphylaxis experi
  • 16. 4. Arthus type immediate hypersensitivity • Animal-rats of both sex • Strain-Wistar or Spargue- Dawley • Body weight 220-280g Principle- • Antigen antibody induced reaction to an inflammatory factors that characterized by edeme, hemorrhage and vasculitis.
  • 17. Procedure • Seven days prior to experiment rats are sensitized by im administration of 0.5 ml of the ovalabulin suspension. • 1st group (treated group) 1hr prior test compound are administered and challenged with 0.5ml of ovalabulin in left hind paw • 2nd group(positive group)-sensitized animal treated with solvent alone. • 3rd group (negative group) non sensitized animals treated with solvent.
  • 18. Evaluation • The change in footpad thickness is expressed as percent from the vehicle control group. Thickness can be measured by calipers. Modification • Omote et al.(1994)-sheep red blood cell suspension used for immunization.
  • 19. 5. Delayed type hypersensitivity Principle • Delayed type hypersensitivity is a reaction of cell mediated immunity and becomes visible after 16-18hr. Procedure • 7 days prior, rats are sensitized by im administration of 0.5 ml ovalbulin. • After seven days again 0.1 of 0.04% of ovalbulin injected in the left hind paw.
  • 20. • Footpad thickness is measured immediately and 24hr after of administration. Modification • Mizukoshi et al.(1994)- they use sheep red blood cells for immunization.